Breaking News, Collaborations & Alliances

eXmoor Pharma, KU Leuven Partner to Support New Cell & Gene Therapy Hub

A key focus of the partnership will be the development of adeno-associated virus (AAV) gene therapy programs using intellectual property from KU Leuven.

Author Image

By: Charlie Sternberg

Associate Editor

eXmoor Pharma, an integrated cell and gene therapy CDMO with embedded consultancy expertise, has entered into a strategic partnership with KU Leuven, one of Europe’s leading academic institutions, to support a new cell and gene therapy hub. The collaboration brings together complementary scientific, regulatory and manufacturing capabilities to accelerate innovative cell and gene therapies from bench to first-in-human trials. The cell and gene therapy hub has been established by KU Leuven and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters